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Polyamines are essential for growth. Although the mechanisms, through which they
exert their growth sustaining activities have only paftly been elucidated, it has firmly
been established that polyamine depletion leads to growth inhibition Consequently,
polyamine depletion is currently investigated as a modality for anticancer and antipa-
rasitic (i e trypanosomas) therapy. In contrast, in the event that polyamines become
the limiting factor during normal growth processes (e.g newborns, cure from
inluries), polyamine supplementation may prove clinically relevant.
Polyamine homeostasis is governed by biosynthesis, retroconversion, terminal catabo-
lism, uptake and secretion. The two key enzymes in polyamine biosynthesis are
ornithine decarboxylase (ODC) and S-adenosylmethionine decarboxylase (SAMdc).
ODC converts orniÍhine to putrescine, whereas SAMdc provides the aminopropyl
donor that is needed to convert putrescine to spermidine, and spermidine to spermine
Spermine and spermidine can be retroconverted to spermidine and putrescine, respec-
t ively, via the so cal led retroconversion pathway. I t  proceeds via the respective N-
acetylated intermediates. Terminal degradation occurs by oxidative deamination,
leading to formation of non-cr-amino acids. Cells dispose of Na - and energy-depen-
dent polyamine uptake systems, which al low sequestrat ion of extracel lular
polyamines. A review of polyamine homeostasis and i ts manipulat ion for oncological
and developmental purposes is given in Chapter I . l .
Many analytical methods for the determination of polyamines and some of their
metaboli tes are at our disposal. They are at the basis of our present knowledge of
polyamine biochemistry and (patho)physiology, including the design of rational treat-
ment schedules with polyamine biosynthesis inhibitors or others. Chapter I .2 reviews
chromatographic techniques and detection methods for polyamines, which have been
published during about the past 20 years. Chromatography with on-l ine detection is
the most commonly appl ied profi l ing method for polyamines, N-acetylpolyamines and
their non-q-amino acid metaboli tes. Cation-exchange and reversed-phase high-perfor-
mance liquid chromatography require pre- or post-column derivatization, followed by
UVA/IS spectrophotometric or f luorimetr ic detection. Isolat ion and derivatization
precede gas chromatography with flame ionization, nitrogen/phosphorus, electron
capture or mass spectrometric detection. From the literature it is clear that, as with the
analyses of many other analytes, high-performance liquid chromatography and gas
chromatography of polyamrnes are not competit ive techniques, but rather supple-
mentary.
ONCOLOGY
Growth arrest mediated by polyamine depletion is reversible. The arrest is often
accompanied by altered cell cycle phase distribution, leading to accumulation in either
one of the phases of the cel l  cycle. These features al low manipulat ion of tumor cel l
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kinetics, since polyamine depletion and subsequent repletion may lead to a synchro-
nously dividing tumor cell population. Administration of phase specific chemotherapy
at the time of maximal appearance in the chemotherapy-sensitive phase may enhance
tumor cel l  ki l l .
The most widely studied polyamine biosynthesis inhibitor is the irreversible enzyme-
activated ODC inhibitor cr-difluoromethylornithine (DFMO) DFMO antitumor
activity in vivo proved disappointing due to the availability of exogenous polyamines,
notably putrescine, deriving from the gastrointestinal (GI) bacteria, the diet and the
retroconversion pathway. Combination of total GI decontamination, polyamine
deficient dret, and inhibition of retroconversion potentiates DFMO antitumor activrty
in vivo. Growth of i .p. Ll2l0 leukemia in mice is profoundly inhibited, and the
Ll2l0 cel ls accumulate in GoG, phase of the cel l  cycle. The need of GI decontamina-
tion encounters several serious clinical drawbacks. We investigated whether binding
of GI polyamines by oral adminlstration of Dowex 50 WX8, a strong cation-exchange
resin, either loaded with Na-, H' or Cat-, is an alternative to GI decontamination. The
results are described in Chapter I I . l .  Dowex-Na grossly increased water consump-
t ion. Dowex-H- elevated putrescine in some organs, most l ikely because of augmen-
ted bacterial putrescine production fol lowing decreasing GI luminal pH. Lewis lung
carcinoma bearing C57BL mice, either or not treated with DFMO, were fed rodent
chow wi th  o r  w i thout  l0o /o  Dowcx-H or  Dowex-Cat . l ' he  res ins  d id  no t  po ten t ia te
DFMO-induced moderate tumor growlh inhibition and did not cause additional
polyamine deplet ion Compared with DFMO treatment, combined treatment of Ll2l0
bearing DBA-2 mice with Dowex-Car'  and DFMO did not increase survival t ime. l t
was concluded that cation exchange resins can not replace decontamination.
Since the DFMO anti tumor activi ty in vivo proved disappoint ing, the search for other
ODC inhibitors may provide us with compounds which are less confounded by their
poor pharmacokinetic prof i le. A group of ODC inhibitors, that may prove cl inical ly
potent, are the amrnooxy polyamine analogues, one of which is 4-amino-l-ami-
nooxycyclohexane (CGP 52622). In Chapter II.3 we compared the in viÍro effects of
the ODC inhibitors CGP 52622 and DFMO on i .p. Ll2l0 growrh, viabi l i ty and poly-
amine contents. We also studied whether co-treatment with the copper-amine oxidase
inhibitor aminoguanidine improves the effects of CGP 52622. Dose-effect curves
showed that the ICr,,  of CGP 52622 is l3 fold lower, compared with DFMO, and that
both CGP 52622 and DFMO are non-toxic in the studied dose-ranges (viabi l i ty
>90oÁ) Both inhibitors depleted putrescine and spermidine dose-dependently. but had
l i t t le effect on spermine. Growth inhibit ion by CGP 52622 is rapid (<21 h), compared
with DFMO (>24 h). AG potentiated the CGP 52622 growth inhibitory effect. We
conclude that CGP is a rapidly acting, non-toxic, potent growth inhibitor that acts via
specif ic ODC rnhibrtron. Prel iminary data suggest that CGP 52622 is a copper-amine
oxidase substrate. This feature would imply that CGP 52622 will have to be admi-
nistered in combination with aminocuanidine. which does not favor i ts appl icat ion.
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Putrescine is much less capable of supporting growth than the polyamines spermidine
and spermine. Since putrescine is most likely the extracellular polyamine that abo-
lishes the cytostatic effect of DFMO in vivo, we hypothesized that combination of
DFMO with an inhibitor of SAMdc would present a valuable alternative to G[ decon-
tamination. Until recently, the available SAMdc inhibitors were either too toxlc
Imethylglyoxal bis(guanylhydrazone); MGBG] or ineffect ive [5'-{[(Q-a-amino-2-
butenyl]methylamino)-5'-deoxyadenosine; AbeAdo], In ChapÍer I I .3 we describe a
study on the in vivo growth rnhibitory effect of monotherapy with the newly synthesi-
zed SAMdc inhibitor 4-amidinoindan-l-one 2'-amidinohydrazone (CGP 48664A).
Ll210 bearing DBA-2 mice were treated for four days, start ing from 24 h after ip.
tumor cell inoculation, after which all mice were sacrificed. CGP 486644 caused
dose-related exponential decreases of I-1210 cel l  numbers and spermidine and sper-
mine contents. Putrescine contents increased exponential ly. Polyamine changes in
spleen and l iver were less profound. Ll2l0 growth inhibit ion was not accompanied
by changes in cell cycle phase distribution. It was concluded that CGP 48664A is an
effective inhibitor of S-adenosylmethionine decarboxylase, but that CGP 48664A-
induced changes in intracel lular polyamine composit ions are not necessari ly the
underlying cause of growth inhibit ion, because the highly selective SAMdc inhibitor
AbeAdo exerts similar changes in Ll2l0 polyamine contents without profound
growth inhibitron.
Thus, CGP 48664A inhibits Ll2l0 growth in vivo without causing alterat ions in cel l
cycle phase distribution. Chapter II.4 describes studies on the ir vjvo effects of CGP
48664A, DFMO and the CGP 48664A-DFMO combination. End points were tumor
growth, cell cycle phase distribution and polyamine contents. DBA-2 mrce were
treated from day I to 4 after i .p. Ll2I0 cel l  inoculat ion and sacri f iced on day 5.
Relat ive to control,  CGP 48664A, DFMO and CGP 48664A-DFMO combination
reduced Ll2l0 cel l  numbers by 33,43 and 857:o, respectively. I t  was concluded that
CGP 48664A potentiated the cytostatic effect of DFMO in vivo. The resulting growth
inhibition was accompanied by accumulation in GoG,- and GM-phases and reduction
of putrescine and spermidine These observations were similar to those previously
obtained usrng combined treatment with DFMO, total GI tract decontamrnation,
polyamine poor diet and MDL 72527.
We elaborated on the observation that the competit ive SAMdc inhibitor CGP 486ó4A
inhibits growth more effectively than the irreversible SAMdc inhibitor AbeAdo, while
having similar effects on polyamine contents. We hypothesized that growth inhibition
by CGP 48664A is not merely accomplished by SAMdc inhibit ion. Concentrat ion-
related growth inhibitory effects of AbeAdo, CGP 48664A and methylglyoxal brs(gu-
anylhydrazone) (MGBG) were investigated in Ll2l0 cells that lacked functional
SAMdc activi ty due to pre- and ongoing- incubation with l0 pM AbeAdo. This was
proven by showing negligible conversion of added deuterium labeled spermidine to
labeled spermine. The results of this study are presented in Chapter II.5. Increasing
AbeAdo on top of the l0 pM AbeAdo background ( indicated AbeAdo/I0 pM Abe
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Ado) did not affect Ll2l0 cel l  numbers, viabi l i ty, nor polyamine contents. MGBG/I0
pM AbeAdo proved highly toxic. CGP 48ó64Ail0 pM AbeAdo did not affect Ll2l0
polyamine contents, but cell numbers and viability decreased dose-dependently to 50
and 709'o of control,  respectively. We conclude that CGP 48664A inhibits Ll2l0
growth not only through SAMdc inhibition, but also by an as yet pooÍly understood
second effect with higher IC,o. The alleged second effect of CGP 48664A appears
important for its potent antitumor effect.
Polyamine replenishment of DFMOiCGP 48664A treated tumor cells leads, theoreti-
cally, to their synchronous entry into S-phase. To avoid confounding factors, this
concept was init ial ly tested with cultured Ll2l0 cel ls. The results are in Chapter
II.ó. Cells were exposed to CGP 48664A and DFMO concentÍations that caused ge-
nerally similar changes in polyamine contents and in cell cycle phase distribution as
previously found in vlvo. Polyamine replenishment was performed with Nr-acerylsper-
mine (NI-acSp), since NI-acSp is less toxic than the free polyamines. I t  was hypothe-
sized that the cells would retroconvert Nl-acsp to spermidine and that this would
al low them to resume growth. Inf luences of Nr-acSp dose- exposure t ime. amino-
guanidine ( inhibitor of polyamine oxidative deamination) and cel l  numbers (at l0
nmol N'-acSp) on percentage S-phase, polyamine contents and viabi l i ty were studied.
DFMO/CGP 48664A decreased percentage S-phase from 58 to 260Á, decreased
spermidine and spermine contents 3 fold, but did not affect viability. With increasing
N'-acSp dose, S-phase percentage and spermidine contents increased concomitantly,
reaching plateau values that were comparable with those of untreated controls. S-
phase and spermidine content increased from 4-ó h after Nr-acSp adminislral ion, rea-
ching plateau values from I I  and 6 h, respectively Intracel lular Nr-acSp content was
dose-dependent and increased linearly to reach plateau values from 8 h. Aminoguani-
dine did not affect any of these parameters. Addit ion of l0 nmol N'-acSp to decreas-
ing numbers of DFMO/CGP 48664A-treated cel ls caused increasing S-phase percen-
tage, spermidine and Nr-acSp contents. We concluded that cel l  cycle kinetics of
cultured L1210 cel ls can be manipulated by the induction of growth inhibit ion with
DFMO/CGP 48664A and i ts subsequent abol ishment with Nr-acSp. Nr-acSp accumu-
lation rate and its subsequent conversion rate to spermidine proved relatively slow,
compaÍed with intracellular spermrdine needs. The data support the notion that
spermidine is the most important polyamine for growth.
The same concept was subsequently tested in i .p. Ll2l0 leukemia bearing mice.
These results are presented in Chapter I I .7. From 24 h after i .p. Ll2l0 inoculat ion,
DBA-2 mice received 2 50 mg CGP 48664Alkg i .p. once dai ly and 500 mg
DFMO/kg i .p. twice dai ly. On day 5 they received 3x2500 nmol N'-acSp i .p. with l5
minutes intervals. L12l0 cel l  numbers, S-phase percentage and polyamine contents,
and liver and spleen polyamine contents were monitored in the following 48 h. Four
days treatment with CGP 48664A/DFMO reduced Ll2l0 cel l  numbers, S-phase, and
spermidine. N'-acSp treatment increased Ll2l0 spermidine from <8 h and percentage
S-phase from 12 h. Maxima for spermidine and S-phase were reached at <8 and l8 h,
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respectively. These were below the levels of untreated controls. Decreases were noted
from 12 and l8 h, respectively. Nr-acSp was detectable in Ll2l0 from 0-18 h. Liver
spermidine was decreased by CGP 486ó4A/DFMO, and was restored by Nr-acSp.
Liver Nt-acSp and Nr-acSd increased from <8 h, reached maxima at <8 and l0 h,
respectively, and were undetectable from 15 h. It was concluded that the in vivo
growth inhibitory effect of CGP 48664A,/DFMO is reversible by Nr-acSp treatment.
The l iver is probably involved in N'-acSp terminal catabolism. The effect of the
polyamine deplet ion-replet ion scheme on S-phase cel l  numbers may be much more
profound than present est imates from 5-bromo-2'-deoxyuridine incorporation.
Summarizing the above experiments, all aimed al inte(èrence with polyamine
homeoslasis 
-for oncological purposes, we may conclude lhal manipulation of tumor
cell kinetics is indeed achievable, using the CGP J8ó6JA DI:lvlO Nl-acSp poll,amine
depletionirepleÍion scheme. It musÍ, however, be sÍressed that the experiments were
carried out v'ith the munne Ll2l0 leukemia model, which is characterized hy an
unusually high percentage S-phase (60%) Conceivably, polyamine replenishment
Jolloving polvamine depletion in this model may noÍ be expecíed to cause any gain in
S-phase percentage. Ií remains to he estahlished v,hether such re.;ults can be obtained
in animal Íumor models Íhat more closelv resemble the human situaÍion.
NEONATOLOGY
Polyamine supplementation may be beneficial in the event of insuff icient polyamine
supplies, e.g. in periods of rapid physiological grow.th. Theoretical ly, de novo
synthesis of any body constituent may under these conditions be insufficient to cover
the exceptional ly high needs, a situation that for some consti tuents causes their
conditional essentiality for (increased) uptake from extraneous sources. Polyamines
may be such consti tuents, since dietary polyamines have been reported to induce
precocious maturation of the gut in rats. By st imulat ing the closure of t ight junctions
they may prevent non-specific absorption of macromolecular allergens. Human milk
contains higher concentrat ions of spermidine and spermine than formula milk,
suggesting that supplementation of formula milk may be relevant in the management
of notably premature newboms. We devoted two studies to the significance of dietary
polyamines in early neonatal l i fe
We estimated 24 hour polyamine intakes from mature human milk by newboms and
evaluated the outcome in the l ight of i ts potential contr ibution to mucosal growth.
The results are in Chapter I I I . I .  Human milk polyamine concentrat ions were deter-
mined on days 16+4 (n:98), 44+3 (n=97) and 9116 (n=25) after del ivery Median
concent ra t ions  ( in  pmol / l )  were :  pu t resc ine  0 .77 ,0 .63 ,  0 .63 ;  spermid ine  4 .54 ,3 .0 '1  ,
2 .73 ,  spermine 3 .76 ,  2 .90 ,  2 .22 ;  and to ta l  po lyamines  9 .82 ,  6 .83 ,  5 .71 ,  respec t ive ly .
Estimated median outputs (rn pmoll24 hours) were: putrescine 039, 0.32, 0.40.
spermid ine  245,  |  84 ,  1 .63 ;  spermine 194,  1 .64 ,  1 .32 ;  and to ta l  po lyamines  4 .93 ,
3 85, 3 29, respectively Concentrat ions of spermidine, spermine and total polyamines
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decreased during the observation period. Estimated median newborn 24 hour total
polyamine intake from mature milk corresponds with daily requirement for about
0.13-0.20 g mucosal t issue tncrement. Putrescine, spermidine and spermine milk/plas-
ma rat ios are estimated to be l6-19, 14-24 and,44-75, respectively. The data suggest
that milk polyamines derive from the high polyamine contents in the mammary gland
and that they may have importance in newbom nutntlon.
In Chapter I lL2, we investigated organ distr ibution and metabolic fate of oral ly
administered stable isotopical ly labeled polyamines in rat pups. Pups received tetra-
deuterium labeled putrescine (Pu-d4; 3 pmol), spermidine (Sd-da;5 pmol), spermine
(Sp-da; 3 pmol), or physiological sal ine twice dai ly on postnatal days 7-10 or l2-15.
They were ki l led days l0 and 15, respectively. Treatments did not affect growth rate,
but caused lower werghts of liver, kidneys and heart. Maltase activity in the ileum
increased. lactase decreased. whereas sucrase and diamine oxidase did not change.
Villus and crypt lengths increased. Organ polyamine pools were labeled to different
extents. lrrespective of the oral ly administered polyamine al l  organs contained Pu-d4,
Sd-d4 and Sp-d4. Administered Pu-d4 and Sd-d4 were recovered mainly as Sd-d4,
whereas Sp-d4 was recovered as Sp-d4 and Sd-d4. Total polyamines in cecum, colon
and erythrocytes increased, but increases were only to a minor extent on account of
labeled polyamines. Our data confirm precocious gut maturation by exogenous
polyamines. The putrescine moiety appears to be the l imit ing factor. The exogenous
polyamines are distributed among all investigated organs. -fhey are not only used for
the synthesis of higher polyamines, but also retroconverted to their precursors
Changes in erythrocyte polyamine contents suggest precocious st imulat ion of erythro-
pores i  s .
Summarizing the ahove experin ents. both qimed al eventual inlerlèrence vith poly-
antine homeostasis in newhorns. we mqy conclude lhal human rnilk seems lo contain
plD!.tiologically re levant amounts of polyamlng5. 'l'hese polyonines may not only play
a role in gut maÍuraíion.!'heir appeLtranL'e in oilrcr orgcuts. Íheir ac:tirc tfiterLon-
version and the observed changes in hernatopoiesis suggest thar they also play roles
in non-gul Íissues, al leasÍ in ral pups. IÍ musl be síressed lhat Íhe orally adminis-
lered polyamine doses Ío raÍ pups are non-physiological. They seem, neverÍheless,
non-Íoxic, v'hic'h encourages 
-firther sÍutlies on the role oJ tlietary polyamines in early
nuÍnÍron.
ANALYTICAL CHEMISTRY
Polyamine analogues are compounds that interfere with both polyamine homeostasis
and function for oncologrcal purposes The ideal analogue depletes intracel lular
polyamines by inhibit ion of polyamine biosynthesis and uptake, and by promotion of
polyamine retroconversion and catabolism. In addit ion, i ts intracel lular accumulation
causes occupation of polyamine binding sites without fulf i l l ing polyamine function.
N ' ,N" -b is le thy l )norspermine (BE-3-3-3)  and 1 ,19-b is (e thy lamino) -5 ,10 ,  l5 - t r iazanona-
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decane (BE-4-4-4-4) are among the bis(ethyl)polyamine analogues that may eventual-
ly prove of clinical value. Their further development necessitates development of
analytical methods that preferably enable simultaneous quantification of the relevant
group of metabolically- or functionally- related compounds (profiling method).
In Chapter IV.l ,  we describe a method for the profi l ing of polyamines, N-acetylated
polyamines and the polyamine analogues BE-3-3-3 and BE-4-4-4-4 in Ll2lO murine
leukemia cells by capillary gas chromatography with nitrogen phosphorus detection.
The method makes use of 4 intemal standards.. Prepurification comprises deproteini-
zation, isolation with Sep-Pak silica at pH 9, conversion to heptafluorobutyryl deriva-
tives and postderivatization organic fluid extraction. Within- and between-series
precisions (given as CV's) for analysis of 1-2*l0o cel ls were: putrescine 5.5 and 29.4
o%; spermidine 1.6 and 7.lYo; and spermine 3 2 and 7.60Á, respectively. Within- and
between-series recoveries, relat ive to the respective intemal standards, were in the
70.6-104.7yo range. Accuracy and precision of measurements of BE-4-4-4-4 can
probably be improved by the introduction of a separate pentamine intemal standard.
We conclude that the method can be used for studying the effect of BE-3-3-3 and
BE-4-4-4-4 on cellular levels of the naturally occurring polyamines, their N-acetylated
retroconversron rntermediates, and the levels of BE-3-3-3, BE-4-4-4-4 and their
metaboli tes.
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